Share this article on:

Hyperbaric oxygen therapy does not affect recovery from delayed onset muscle soreness

MEKJAVIC, IGOR B.; EXNER, JASON A.; TESCH, PER A.; EIKEN, OLA

Medicine & Science in Sports & Exercise: March 2000 - Volume 32 - Issue 3 - p 558-563
CLINCAL SCIENCES: Clinically Relevant

MEKJAVIC, I. B., J. A. EXNER, P. A. TESCH, and O. EIKEN. Hyperbaric oxygen therapy does not affect recovery from delayed onset muscle soreness. Med. Sci. Sports Exerc., Vol. 32, No. 3, pp. 558–563, 2000.

Purpose: This study investigated whether hyperbaric oxygen therapy (HBOT) improves recovery after exercise-induced muscle injury.

Methods: Healthy male subjects (N = 24) were randomly assigned to either a placebo group or a HBOT group. Subjects were tested for maximal isometric strength (preexercise) of their right elbow flexors. Each subject then completed a high-force eccentric workout of the elbow flexor muscle group to induce delayed onset muscle soreness (DOMS). On the seven successive days after this workout, the subjects were exposed to a hyperbaric environment of 2.5 ATA for 60 min, inspiring either a normoxic mixture (PIO2 = 0.2 ATA; placebo group) or a hyperoxic gas mixture (PIO2 = 2.5 ATA; HBOT group). Before the eccentric workout and daily for the next 10 d, measurements were obtained regarding: maximal isometric muscle strength of the elbow flexor muscles, right upper arm circumferences, and rating of the perceived muscle soreness.

Results: Isometric strength decreased significantly from preexercise levels of 25.1 ± 3.8 kp to postexercise levels of 12.0 ± 4.6 kp, for the HBOT group, and from 24.6 ± 3.4 kp to 12.5 ± 3.7 kp, respectively, for the placebo group. Over the 10-d recovery period, there was no difference in the rate of recovery of muscle strength between the two groups. Perceived soreness peaked at about 48 h after exercise with no difference between groups. Also, the exercise-induced increases in arm circumference were similar in the two groups.

Conclusions: These results indicate that HBOT is not an effective therapy for the treatment of DOMS.

Department of Sports & Exercise Science, Faculty of Science, University of Portsmouth, Portsmouth, UNITED KINGDOM; Faculty of Medicine, University of Ljubljana, Ljubljana, SLOVENIA; and Division of Clinical Physiology, Karolinska Institute, Huddinge Hospital, S-14186 Huddinge, SWEDEN; Swedish Defence Research Establishment, Aviation Medicine, Karolinska Institute, S-17177 Stockholm, Sweden

Submitted for publication July 1998.

Accepted for publication March 1999.

Address for correspondence: Igor B. Mekjavic, Department of Automation, Biocybernetics and Robotics, Institute Jozef Stefan, Jamova 39, 1000 Ljubljana, Slovenia. E-mail: eubs@guest.arnes.si.

©2000The American College of Sports Medicine